The journal of ‘CardioRenal Medicine’ explores the mechanisms by which obesity and other metabolic abnormalities promote the pathogenesis and progression of heart and kidney disease (cardiorenal metabolic syndrome). It provides an interdisciplinary platform for the advancement of research and clinical practice, focussing on translational issues. Attention is paid to the fact that some metabolic abnormalities cluster with heart and chronic kidney disease, and collectively this is called the cardiorenal metabolic syndrome. Moreover, certain metabolic abnormalities of the heart promote impaired coronary artery endothelial function, diastolic dysfunction and ischemic reconditioning that parallel glomerular hyperfiltration and impairments in proximal tubule handling of sodium and albumin. Another point of focus is the role of the obesity epidemic in promoting the increasing incidence of heart and kidney disease in industrialized countries and the prevailing problems of insufficient exercise and excessive consumption of cheap, unwholesome food in promotion of the cardiorenal metabolic syndrome in both adults and children.
CardioVascular and Interventional Radiology publishes peer-reviewed original research work including laboratory and clinical investigations, technical notes, case reports, brief communications, and letters to the editor, as well as review articles, opinions, editorials, and special invited submissions in the field of cardiac, vascular, and interventional radiology. This is the official journal of the Cardiovascular and Interventional Radiological Society of Europe, the Japanese Society of Interventional Radiology, and the British Society of Interventional Radiology.
Established in 1937, Cardiology provides a forum for scientific progress in the prevention, recognition, and treatment of heart disease. Bridging clinical, preclinical, and translational research, the contents include original research articles, topical reviews, and expert opinion commentaries. Sections such as “Coronary Artery Disease”, “Imaging”, “Electrophysiology and Arrhythmia”, or “eCardiology/Digital Health” highlight the wide variety of subspecialty areas covered and feature new developments in noninvasive and invasive diagnostic methods, epidemiology, as well as pharmacological, preventive, and mechanical/surgical therapies.
Cardiology publishes articles relevant to cardiologists, cardiac surgeons, internists, clinical physiologists, pharmacologists, and professionals from other areas of medicine interested in cardiovascular diseases.
Published four times a year—in February, May, August, and November—Cardiology Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Tailored to meet the needs of those in the field of cardiology, each issue focuses on a single cardiology topic, including acute coronary syndromes/cardiac emergencies, coronary artery disease, heart failure, heart rhythm disorders, and much more.
Cardiology Journal (formelly Folia Cardiologica) is a scientific, peer-reviewed journal covering a broad spectrum of topics in cardiology. The journal has been published since 1994 and over the years it has become an internationally recognized journal of cardiological and medical community. This growing interest in Cardiology Journal is mostly due to constantly increasing quality of original papers submitted to the journal from all-over-the-world, excellent educational content with interesting review and how to do articles, and instructional case reports. Cardiology Journal is the journal for practicing cardiologists, researchers, and young trainees benefiting from broad spectrum of useful educational content. All these factors led the journal to receiving an international indexation in Medline, EMBASE, Index Copernicus (9.00), PBL GBL and Thomson Reuters database. The journal remains an official journal of several Working Groups of the Polish Cardiac Society.
Cardiology Research and Practice is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of cardiology.
Cardiology and Therapy is a fully open access, internationally peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3-4 weeks from acceptance). Emphasis is placed on the publication of high-quality practical and clinical research around new and existing therapies in all areas of cardiology, including interventional cardiology. Studies relating to diagnosis, health economics, outcomes research, patient care, management, and education are also encouraged. The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, drug reviews, case reports, and short communications. Moving forward from traditional publishing, Cardiology and Therapy offers a range of additional features designed to increase visibility and readership. As such, each paper is accompanied by a bulleted slide summary giving a time-efficient overview of the content to a wider readership. All submissions have the option to include slide sets, video components, animations, and/or interactive case studies.Cardiology and Therapy publishes supplements and special issues (in English or a local language). Material appropriate for supplements/special issues include: sponsored meeting proceedings, roundtable discussions, workshop reports, case series, and collections of articles on the same topic. All articles are subject to peer review, and must adhere to the IJCME and GPP policies on acknowledgments/disclosures. Proposals for supplements are welcomed, and should be addressed to nicola.cartridge@springer.comFor authors: Upon acceptance of your article for publication, you will be required to pay the article open access fee of £175/€200/$260 per printed page. This will enable you to keep the copyright: you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open, access.
American Heart Association members are eligible for a 20% discount on subscription rates.Edited by some of the world's best-known authorities, Cardiology in Review provides readers with critical state-of-the-art reviews of topics that are relevant to current and future cardiovascular medicine and surgery practice. Each issue includes articles by leading international experts in the areas of cardiovascular epidemiology, pathophysiology, diagnostics, prevention, and therapeutics.Indexed in: MEDLINE/PUBMED, EMBASE, SCOPUS, Science Citation Index Expanded, Current Contents/Clinical MedicineWebsite: www.cardiologyinreview.com.